Your browser doesn't support javascript.
loading
Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer.
Rafnar, Thorunn; Sulem, Patrick; Thorleifsson, Gudmar; Vermeulen, Sita H; Helgason, Hannes; Saemundsdottir, Jona; Gudjonsson, Sigurjon A; Sigurdsson, Asgeir; Stacey, Simon N; Gudmundsson, Julius; Johannsdottir, Hrefna; Alexiusdottir, Kristin; Petursdottir, Vigdis; Nikulasson, Sigfus; Geirsson, Gudmundur; Jonsson, Thorvaldur; Aben, Katja K H; Grotenhuis, Anne J; Verhaegh, Gerald W; Dudek, Aleksandra M; Witjes, J Alfred; van der Heijden, Antoine G; Vrieling, Alina; Galesloot, Tessel E; De Juan, Ana; Panadero, Angeles; Rivera, Fernando; Hurst, Carolyn; Bishop, D Timothy; Sak, Sei C; Choudhury, Ananya; Teo, Mark T W; Arici, Cecilia; Carta, Angela; Toninelli, Elena; de Verdier, Petra; Rudnai, Peter; Gurzau, Eugene; Koppova, Kvetoslava; van der Keur, Kirstin A; Lurkin, Irene; Goossens, Mieke; Kellen, Eliane; Guarrera, Simonetta; Russo, Alessia; Critelli, Rossana; Sacerdote, Carlotta; Vineis, Paolo; Krucker, Clémentine; Zeegers, Maurice P.
Afiliación
  • Rafnar T; deCODE Genetics/AMGEN, Reykjavik 101, Iceland thorunn.rafnar@decode.is kstefans@decode.is.
  • Sulem P; deCODE Genetics/AMGEN, Reykjavik 101, Iceland.
  • Thorleifsson G; deCODE Genetics/AMGEN, Reykjavik 101, Iceland.
  • Vermeulen SH; Department for Health Evidence Department of Genetics and.
  • Helgason H; deCODE Genetics/AMGEN, Reykjavik 101, Iceland School of Engineering and Natural Sciences and.
  • Saemundsdottir J; deCODE Genetics/AMGEN, Reykjavik 101, Iceland.
  • Gudjonsson SA; deCODE Genetics/AMGEN, Reykjavik 101, Iceland.
  • Sigurdsson A; deCODE Genetics/AMGEN, Reykjavik 101, Iceland.
  • Stacey SN; deCODE Genetics/AMGEN, Reykjavik 101, Iceland.
  • Gudmundsson J; deCODE Genetics/AMGEN, Reykjavik 101, Iceland.
  • Johannsdottir H; deCODE Genetics/AMGEN, Reykjavik 101, Iceland.
  • Alexiusdottir K; Department of Medicine.
  • Petursdottir V; Department of Pathology.
  • Nikulasson S; Department of Pathology.
  • Geirsson G; Department of Urology and.
  • Jonsson T; Faculty of Medicine, University of Iceland, Reykjavik 101, Iceland Department of Surgery, Landspitali-University Hospital, Reykjavik 101, Iceland.
  • Aben KK; Department for Health Evidence Comprehensive Cancer Center The Netherlands, Utrecht, The Netherlands.
  • Grotenhuis AJ; Department for Health Evidence.
  • Verhaegh GW; Department of Urology, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands.
  • Dudek AM; Department of Urology, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands.
  • Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands.
  • van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands.
  • Vrieling A; Department for Health Evidence.
  • Galesloot TE; Department for Health Evidence.
  • De Juan A; Division of Medical Oncolology, Marques de Valdecilla University Hospital, Santander 39008, Spain.
  • Panadero A; Division of Medical Oncolology, Ciudad de Coria Hospital, Coria 10800, Spain.
  • Rivera F; Division of Medical Oncolology, Marques de Valdecilla University Hospital, Santander 39008, Spain.
  • Hurst C; Section of Experimental Oncology, Leeds Institute of Cancer and Pathology, St. James's University Hospital, Leeds LS9 7TF, UK.
  • Bishop DT; Section of Epidemiology & Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS2 9JT, UK.
  • Sak SC; Mid Yorkshire NHS Trust, Pinderfields Hospital, Wakefield WF1 4DG, UK.
  • Choudhury A; Christie Hospital NHS Trust, Manchester M20 4BX, UK.
  • Teo MT; Section of Experimental Oncology, Leeds Institute of Cancer and Pathology, St. James's University Hospital, Leeds LS9 7TF, UK.
  • Arici C; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia, Brescia 1-25125, Italy.
  • Carta A; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia, Brescia 1-25125, Italy.
  • Toninelli E; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia, Brescia 1-25125, Italy.
  • de Verdier P; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm S171 76, Sweden.
  • Rudnai P; Department of Environmental Epidemiology, National Institute of Environmental Health, Budapest H-1450, Hungary.
  • Gurzau E; Health Department, Environmental Health Center, Babes Bolyai University, Cluj-Napoca 3400, Romania.
  • Koppova K; Department of Environmental Health, Regional Authority of Public Health, Banska Bystrica 975 56, Slovakia.
  • van der Keur KA; Department of Pathology, Erasmus MC, Rotterdam 3000 CA, The Netherlands.
  • Lurkin I; Department of Pathology, Erasmus MC, Rotterdam 3000 CA, The Netherlands.
  • Goossens M; Department of General Practice, Catholic University of Leuven, Leuven 3000, Belgium.
  • Kellen E; Leuven University Centre for Cancer Prevention (LUCK), Leuven 3000, Belgium.
  • Guarrera S; Human Genetics Foundation, HuGeF, Torino I-10126, Italy.
  • Russo A; Human Genetics Foundation, HuGeF, Torino I-10126, Italy Department of Medical Sciences and.
  • Critelli R; Human Genetics Foundation, HuGeF, Torino I-10126, Italy Department of Medical Sciences and.
  • Sacerdote C; Human Genetics Foundation, HuGeF, Torino I-10126, Italy Unit of Cancer Epidemiology, University of Torino, Torino 10126, Italy Centre for Cancer Epidemiology and Prevention (CPO Piemonte), Torino 10126, Italy.
  • Vineis P; Human Genetics Foundation, HuGeF, Torino I-10126, Italy Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Krucker C; CNRS, UMR 144, Oncologie Moléculaire, Institut Curie, Paris 75248 Cedex 05, France Institut Curie, Centre de Recherche, Paris 75248 Cedex 05, France.
  • Zeegers MP; Department of Epidemiology & Complex Genetics NUTRIM/Faculty of Health, Medicine and Life Sciences Maastricht University, Maastricht 6200 MD, The Netherlands.
Hum Mol Genet ; 23(20): 5545-57, 2014 Oct 15.
Article en En | MEDLINE | ID: mdl-24861552
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Cromosomas Humanos Par 20 / Proteínas de Unión al Calcio / Péptidos y Proteínas de Señalización Intercelular / Población Blanca / Proteínas de la Membrana Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Mol Genet Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Cromosomas Humanos Par 20 / Proteínas de Unión al Calcio / Péptidos y Proteínas de Señalización Intercelular / Población Blanca / Proteínas de la Membrana Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Mol Genet Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2014 Tipo del documento: Article Pais de publicación: Reino Unido